Recent Progress in Alzheimer's and Parkinson's Diseases
Latest Publications

TOTAL DOCUMENTS

48

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By CRC Press

9781841843209, 9780203028353

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Bone marrow stem cells

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-8 ◽

2005 ◽

pp. 53-60

Author(s):

W-H Zheng ◽

R Quirion

Keyword(s):

Bone Marrow ◽

Bone Marrow Stem Cells

Download Full-text

Acetylcholinesterase, cholinergic signaling and Parkinson’s disease

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-6 ◽

2005 ◽

pp. 33-44 ◽

Author(s):

Y Ben-Shaul ◽

H Bergman ◽

H Soreq

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Cholinergic Signaling

Download Full-text

Activation of Wnt signaling protects from amyloid-_-peptide neurotoxicity

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-46 ◽

2005 ◽

pp. 355-362

Author(s):

N Inestrosa ◽

M Urra ◽

J Scheu ◽

G Farias ◽

A Fisher ◽

...

Keyword(s):

Wnt Signaling ◽

Amyloid Peptide

Download Full-text

The impact of extracellular amyloid-_ (A_) peptides on cortical neurotransmitters and of intracellular A_ accumulation on protein expression

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-45 ◽

2005 ◽

pp. 347-354

Author(s):

C Cuello ◽

K Bell ◽

V Echeverria ◽

E Lopez ◽

A Ribeiro-da-Silva ◽

...

Keyword(s):

Protein Expression ◽

Download Full-text

Pharmacological properties of TV3326, a cholinesterase and brain selective monoamine oxidase inhibitor for the treatment of dementia co-morbid with depression

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-34 ◽

2005 ◽

pp. 257-260

Author(s):

M Weinstock ◽

M Youdim

Keyword(s):

Monoamine Oxidase ◽

Monoamine Oxidase Inhibitor ◽

Oxidase Inhibitor ◽

Pharmacological Properties

Download Full-text

Cholinotrophic alterations in individuals with mild cognitive impairment and Alzheimer’s disease

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-33 ◽

2005 ◽

pp. 249-256

Author(s):

E Mufson ◽

M Fahnestock ◽

J Kordower ◽

S DeKosky

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Mild Cognitive Impairment

Download Full-text

Lack of effect of certoparin in P301L mutant tau pathology

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-28 ◽

2005 ◽

pp. 205-210

Author(s):

M Walzer ◽

M Hejna ◽

S Lorens ◽

J Lee

Keyword(s):

Download Full-text

Water quality and cholesterol-induced pathology

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-27 ◽

2005 ◽

pp. 197-204 ◽

Author(s):

D Sparks ◽

J Lochhead ◽

A Fisher ◽

T Martin

Keyword(s):

Download Full-text

Cerebrospinal fluid phosphorylated tau protein at serine 199 is a useful diagnostic biomarker in Alzheimer’s disease and mild cognitive impairment

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-24 ◽

2005 ◽

pp. 177-182

Author(s):

K Urakami ◽

H Arai ◽

N Itoh ◽

K Ishiguro ◽

H Oono ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cerebrospinal Fluid ◽

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Tau Protein ◽

Phosphorylated Tau ◽

Diagnostic Biomarker ◽

Phosphorylated Tau Protein

Download Full-text

Advances in gene transfer and pharmacological regulation of protein aggregation in the treatment of Alzheimer’s and parkinson’s diseases

Recent Progress in Alzheimer's and Parkinson's Diseases ◽

10.1201/b14441-10 ◽

2005 ◽

pp. 69-80

Author(s):

P Bar-On ◽

E Rockenstein ◽

M Hashimoto ◽

E Masliah

Keyword(s):

Gene Transfer ◽

Protein Aggregation ◽

Parkinson’S Diseases ◽

Pharmacological Regulation

Download Full-text